FI944412L - Proteiinin puhdistus - Google Patents

Proteiinin puhdistus Download PDF

Info

Publication number: FI944412L
Authority: FI; Finland
Prior art keywords: protein purification; purification; protein
Prior art date: 1992-03-24

Application number

FI944412A

Other languages

English (en)

Swedish (sv)

Other versions

FI109202B (fi

FI944412A0 (fi

Inventor

Gail Folena-Wasserman

John H O'grady

Thomas M Smith

John Lifter

Original Assignee

Smithkline Beecham Corp

T Cell Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-24

Filing date

1994-09-23

Publication date

1994-09-23

1994-09-23 Application filed by Smithkline Beecham Corp, T Cell Sciences Inc filed Critical Smithkline Beecham Corp

1994-09-23 Publication of FI944412L publication Critical patent/FI944412L/fi

1994-09-23 Publication of FI944412A0 publication Critical patent/FI944412A0/fi

2002-06-14 Application granted granted Critical

2002-06-14 Publication of FI109202B publication Critical patent/FI109202B/fi

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
- B01D15/327—Reversed phase with hydrophobic interaction
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FI944412A 1992-03-24 1994-09-23 Proteiinin puhdistus FI109202B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US07/857,022 US5252216A (en)	1992-03-24	1992-03-24	Protein purification
US85702292		1992-03-24
US9302732		1993-03-24
PCT/US1993/002732 WO1993018835A1 (en)	1992-03-24	1993-03-24	Protein purification

Publications (3)

Publication Number	Publication Date
FI944412L true FI944412L (fi)	1994-09-23
FI944412A0 FI944412A0 (fi)	1994-09-23
FI109202B FI109202B (fi)	2002-06-14

Family

ID=25324998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI944412A FI109202B (fi)	1992-03-24	1994-09-23	Proteiinin puhdistus

Country Status (19)

Country	Link
US (1)	US5252216A (fi)
EP (1)	EP0643608B1 (fi)
JP (1)	JP3335629B2 (fi)
KR (1)	KR100241172B1 (fi)
AT (1)	ATE193839T1 (fi)
AU (1)	AU659936B2 (fi)
CA (1)	CA2132533C (fi)
DE (1)	DE69328864T2 (fi)
DK (1)	DK0643608T3 (fi)
ES (1)	ES2149206T3 (fi)
FI (1)	FI109202B (fi)
GR (1)	GR3034332T3 (fi)
MX (1)	MX9301655A (fi)
NO (1)	NO310855B1 (fi)
NZ (1)	NZ251601A (fi)
PT (1)	PT643608E (fi)
TW (1)	TW321651B (fi)
WO (1)	WO1993018835A1 (fi)
ZA (1)	ZA932015B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6395888B1 (en) *	1996-02-01	2002-05-28	Gilead Sciences, Inc.	High affinity nucleic acid ligands of complement system proteins
DE4331358A1 (de) *	1992-10-12	1994-04-14	Braun Melsungen Ag	Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
ATE213639T1 (de) *	1993-07-09	2002-03-15	Avant Immunotherapeutics Inc	Proteinreinigung
US5679546A (en) *	1993-09-24	1997-10-21	Cytomed, Inc.	Chimeric proteins which block complement activation
US5429746A (en) *	1994-02-22	1995-07-04	Smith Kline Beecham Corporation	Antibody purification
DE19549420A1 (de) *	1995-04-27	1997-09-18	Braun Melsungen Ag	Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose Faktor alpha (TNF alpha) und bakteriellen Lipopolysacchariden (LPS) aus Vollblut oder/und Blutplasma
EP1300679A3 (en) *	1995-06-26	2004-04-14	Perseptive Biosystems, Inc.	Molecular selection and analysis
JP3737516B2 (ja) *	1995-06-26	2006-01-18	パーセプティブバイオシステムズ，インコーポレーテッド	高速自動化連続流、多次元分子選別および分析
GB9515196D0 (en) *	1995-07-25	1995-09-20	Matthey Rustenburg Refines	Interseparation of platignum group metals
CA2294749C (en) *	1997-06-27	2007-01-02	Life Technologies, Inc.	One step device and process for concentration and purification of biological molecules
US5993653C1 (en) *	1997-08-11	2001-11-06	Phenomenex	Composition and column used in hplc
US6869796B2 (en) *	1997-08-26	2005-03-22	Avaris Ab	Method of introducing organic molecules into target cells
US20070122904A1 (en) *	2000-09-29	2007-05-31	Unisearch Limited	Method and apparatus for culturing cells
US6855263B2 (en) *	2002-07-23	2005-02-15	Nuvue Technologies, Inc.	Rapid process for purification and concentration of plasmin
DE10255508A1 (de) *	2002-11-27	2004-06-17	Forschungszentrum Jülich GmbH	Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
US6913695B2 (en) *	2003-07-08	2005-07-05	Bayer Healthcare Llc	Sanitization of chromatographic media
WO2005012349A2 (en) *	2003-08-01	2005-02-10	Lorantis Limited	Chromatographic process for the purification of notch ligands
US7329353B2 (en) *	2004-01-23	2008-02-12	Amgen Inc.	LC/MS method of analyzing high molecular weight proteins
US7803931B2 (en)	2004-02-12	2010-09-28	Archemix Corp.	Aptamer therapeutics useful in the treatment of complement-related disorders
ATE443870T1 (de) *	2004-07-20	2009-10-15	Symphogen As	Verfahren zur charakterisierung einer polyklonalen zellinie
US20090042274A1 (en) *	2004-07-27	2009-02-12	Genomidea Inc.	Method of Purifying Virus Envelope
CN101039964B (zh) *	2004-08-12	2012-11-14	利普生技术有限公司	带电多糖的分级
EP1738763A1 (en)	2005-06-30	2007-01-03	AVANT Immunotherapeutics, Inc.	Use of complement inhibitory proteins to treat spinal cord injury
WO2007053235A1 (en) *	2005-11-04	2007-05-10	Sachem, Inc.	Cation-exchange displacement chromatography process and cationic organic compounds for use as displacer compounds in cation-exchange displacement chromatography process
DK1991275T3 (en) *	2006-03-08	2014-12-08	Archemix Llc	Complement aptamers AND ANTI-C5 AGENTS FOR USE IN THE TREATMENT OF EYE DISEASES
US20100222560A1 (en)	2009-03-02	2010-09-02	Zymo Research Corporation	Universal column
EP2493922B1 (en)	2009-10-26	2017-02-15	F. Hoffmann-La Roche AG	Method for the production of a glycosylated immunoglobulin
EP2616092B1 (en)	2010-09-15	2018-01-24	Celldex Therapeutics, Inc.	Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
EP2625263B1 (en)	2010-10-08	2020-03-11	Terumo BCT, Inc.	Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
BR112013010098A2 (pt)	2010-10-27	2017-06-13	Celldex Therapeutics Inc	método para melhorar a função de transplante usando um receptor do complemento solúvel tipo i (scr1)
CN106715676A (zh)	2014-09-26	2017-05-24	泰尔茂比司特公司	按计划供养
JP7034949B2 (ja)	2016-05-25	2022-03-14	テルモビーシーティー、インコーポレーテッド	細胞の増殖
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
EP3656841A1 (en)	2017-03-31	2020-05-27	Terumo BCT, Inc.	Cell expansion
WO2023240322A1 (en) *	2022-06-17	2023-12-21	CSL Innovation Pty Ltd	Purification of soluble complement receptor and variants thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2319495C2 (de) *	1973-04-17	1985-01-10	Yeda Research And Development Co., Ltd., Rehovot	Verfahren zum selektiven, reversiblen Binden von Biomolekülen an ein Adsorbens in einer chromatographischen Säule
US4000098A (en) *	1974-08-16	1976-12-28	Palo Alto Medical Research Foundation	Separation of proteins by hydrophobic adsorption
DE3149360A1 (de) *	1981-12-12	1983-06-16	Biotest-Serum-Institut Gmbh, 6000 Frankfurt	"verfahren zur reinigung und/oder phytohaemagglutinin-abtrennung von human-interleukin-2"
US4920196A (en) *	1982-07-30	1990-04-24	Genentech, Inc.	Human lymphotoxin
US4908434A (en) *	1984-04-25	1990-03-13	Sloan-Kettering Institute For Cancer Research	Process for preparing purified interleukin-2
US4743680A (en) *	1985-02-01	1988-05-10	New York University	Method for purifying antihemophilic factor
US4894439A (en) *	1986-05-22	1990-01-16	Cetus Corporation	N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
AU597924B2 (en) *	1985-12-11	1990-06-14	Natinco Nv	Solubilization of protein aggregates
US4770781A (en) *	1986-03-03	1988-09-13	Merck & Co., Inc.	Purification of human interleukin-1 species
US4771128A (en) *	1986-10-10	1988-09-13	Cetus Corporation	Method of purifying toxin conjugates using hydrophobic interaction chromatography
AU609824B2 (en) *	1987-06-15	1991-05-09	Southern Cross Biotech Pty Ltd.	Production of proteins in active forms
US4981799A (en) *	1987-08-21	1991-01-01	Takeda Chemical Industries, Ltd.	Acylamino acid racemase, production and use thereof
US4765903A (en) *	1987-10-06	1988-08-23	Interferon Sciences, Inc.	Purification of monomeric interferon
US5159063A (en) *	1989-02-02	1992-10-27	The United States Of America As Represented By The Department Of Health And Human Services	Isolation and characterization of a 120 kda glycoprotein plasma
US5030352A (en) *	1990-01-25	1991-07-09	Purdue Research Foundation	Coated media for chromatography

1992
- 1992-03-24 US US07/857,022 patent/US5252216A/en not_active Expired - Lifetime
1993
- 1993-03-22 ZA ZA932015A patent/ZA932015B/xx unknown
- 1993-03-24 MX MX9301655A patent/MX9301655A/es unknown
- 1993-03-24 KR KR1019940703342A patent/KR100241172B1/ko not_active Expired - Fee Related
- 1993-03-24 NZ NZ251601A patent/NZ251601A/en not_active IP Right Cessation
- 1993-03-24 DE DE69328864T patent/DE69328864T2/de not_active Expired - Fee Related
- 1993-03-24 EP EP93908538A patent/EP0643608B1/en not_active Expired - Lifetime
- 1993-03-24 AU AU39324/93A patent/AU659936B2/en not_active Ceased
- 1993-03-24 CA CA002132533A patent/CA2132533C/en not_active Expired - Fee Related
- 1993-03-24 JP JP51681493A patent/JP3335629B2/ja not_active Expired - Fee Related
- 1993-03-24 AT AT93908538T patent/ATE193839T1/de not_active IP Right Cessation
- 1993-03-24 WO PCT/US1993/002732 patent/WO1993018835A1/en not_active Ceased
- 1993-03-24 DK DK93908538T patent/DK0643608T3/da active
- 1993-03-24 PT PT93908538T patent/PT643608E/pt unknown
- 1993-03-24 ES ES93908538T patent/ES2149206T3/es not_active Expired - Lifetime
- 1993-07-27 TW TW082105986A patent/TW321651B/zh active
1994
- 1994-09-23 FI FI944412A patent/FI109202B/fi not_active IP Right Cessation
- 1994-09-23 NO NO19943546A patent/NO310855B1/no unknown
2000
- 2000-09-06 GR GR20000402020T patent/GR3034332T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE193839T1 (de)	2000-06-15
KR950700779A (ko)	1995-02-20
EP0643608A1 (en)	1995-03-22
EP0643608B1 (en)	2000-06-14
KR100241172B1 (ko)	2000-02-01
JP3335629B2 (ja)	2002-10-21
NO310855B1 (no)	2001-09-10
ES2149206T3 (es)	2000-11-01
FI109202B (fi)	2002-06-14
MX9301655A (es)	1994-03-31
DE69328864T2 (de)	2000-12-14
PT643608E (pt)	2000-11-30
US5252216A (en)	1993-10-12
TW321651B (fi)	1997-12-01
CA2132533A1 (en)	1993-09-30
AU3932493A (en)	1993-10-21
FI944412A0 (fi)	1994-09-23
DE69328864D1 (de)	2000-07-20
JPH07505469A (ja)	1995-06-15
NO943546L (no)	1994-11-23
EP0643608A4 (en)	1997-11-26
AU659936B2 (en)	1995-06-01
DK0643608T3 (da)	2000-10-02
NO943546D0 (no)	1994-09-23
ZA932015B (en)	1994-09-21
WO1993018835A1 (en)	1993-09-30
GR3034332T3 (en)	2000-12-29
NZ251601A (en)	1997-03-24
CA2132533C (en)	2004-01-13

Publication	Publication Date	Title
FI944412L (fi)	1994-09-23	Proteiinin puhdistus
DK91192D0 (da)	1992-07-10	Protein
FI932282A7 (fi)	1993-11-22	Proteiini C-johdannaisia
FI950024L (fi)	1995-02-17	Aldehydikovetettu proteiiniliima
FI962041A7 (fi)	1996-06-14	Hemoglobiinin puhdistus
FI952574A7 (fi)	1995-05-26	Glykosyylitransferaasiaktiiviset proteiinit
FI955306L (fi)	1995-11-06	Plasmaproteiinien puhdistus
DK132892D0 (da)	1992-10-30	Proteiner
ATA255692A (de)	1994-10-15	Sportschuh
NO930523D0 (no)	1993-02-15	Skrukork
ATA236892A (de)	1996-12-15	Rotornut
FI934588A0 (fi)	1993-10-18	Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
FI923311L (fi)	1993-01-25	Proteiner
DE69333165D1 (de)	2003-10-02	Elektrophoresevorrichtung
FI950264A7 (fi)	1995-01-20	Pikkuleipiin liittyviä parannuksia
DE69228669D1 (de)	1999-04-22	Proteinsequenzierung
DK178089D0 (da)	1989-04-13	Proteinoprensningsfremgangsmaade
ATA227792A (de)	1994-11-15	Sportschuh
DK120792D0 (da)	1992-09-30	Protein
SE9502203L (sv)	1995-08-01	Reningsförarande
SE9202239D0 (sv)	1992-07-24	Emanuelle ii
BR9202399A (pt)	1994-01-18	Jifo ii
FI248U1 (fi)	1992-09-10	Symmetriskt gaongjaern
KR930017669U (ko)	1993-08-20	어린애용 보행기
FI935782A7 (fi)	1994-06-22	Massaa pilkkova apuaine

Legal Events

Date	Code	Title	Description
1999-04-12	HC	Name/ company changed in application	Owner name: SMITHKLINE BEECHAM CORPORATION
2007-09-30	MA	Patent expired